设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2019 年第 6 期 第 14 卷

急诊科慢性阻塞性肺疾病急性加重合并呼吸衰竭无创正压通气治疗时机的研究

Optimal timing of noninvasive positive pressure ventilation for acute exacerbation of chronic obstructive pulmonary disease with respiratory failure patients in emergency department

作者:张莹索旻甄雷张向群魏兵王晓刘禹庚曾红

英文作者:

单位:100043首都医科大学附属北京朝阳医院西院急诊科(张莹、张向群、魏兵、刘禹庚、曾红);100029首都医科大学附属北京安贞医院急诊危重症中心(索旻、甄雷、王晓)

英文单位:

关键词:慢性阻塞性肺疾病;呼吸衰竭;无创正压通气

英文关键词:

  • 摘要:
  • 【摘要】目的    探讨无创正压通气(NPPV)在急诊科慢性阻塞性肺疾病急性加重(AECOPD)合并呼吸衰竭患者中应用的时机。方法    选取首都医科大学附属北京朝阳医院西院2015年10月至2019年1月急诊就诊的110例AECOPD合并呼吸衰竭患者,根据启动NPPV治疗的时机分为对照组(52例)和观察组(58例),观察组患者存在NPPV指征后即刻行NPPV治疗;对照组患者在发现存在NPPV指征后由于患者不愿配合、医疗条件限制等客观因素延迟行NPPV治疗。比较2组患者接受NPPV治疗2 h后临床表现、动脉血气指标、累计NPPV时间、气管插管率及病死率。结果    与治疗前相比,2组治疗2 h后的动脉血氧分压及血氧饱和度均有明显改善(均P<0.05)。观察组治疗后pH值(7.37±0.09比7.28±0.08)、动脉血二氧化碳分压(PaCO2)[(67±14)mmHg(1 mmHg=0.133 kPa)比(82±19)mmHg]、碱剩余[10.5(6.9,14.2)mmol/L比10.2(5.4,12.9)mmol/L]、乳酸浓度[0.8(0.6,1.3)mmol/L比 1.1(0.7,1.6)mmol/L]均优于治疗前(均P<0.05)。观察组ΔpH值和ΔPaCO2均明显高于对照组,差异均有统计学意义(均P<0.001)。观察组的累计NPPV时间比对照组明显缩短[5.0(2.0,9.3)d比6.5(4.0,9.0)d],差异有统计学意义(P=0.048)。对照组与观察组气管插管率[3.8%(2/52)比0]与住院期间病死率[11.5%(6/52)比3.4%(2/58)]差异均无统计学意义(均P>0.05)。结论    急诊科收治符合NPPV指征的AECOPD合并呼吸衰竭患者早期应用NPPV,可以有效纠正缺氧及高碳酸血症,缓解呼吸肌疲劳,改善临床症状,缩短无创通气治疗时间。

  • 【Abstract】Objective    To investigate the optimal timing of noninvasive positive pressure ventilation(NPPV) in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD) with respiratory failure in emergency department. Methods    A total of 110 AECOPD patients with respiratory failure admitted to Department of Emergency, Western Hospital of Beijing Chaoyang Hospital, Capital Medical University from October 2015 to January 2019 were enrolled. According to the timing of NPPV, the patients were divided into early application group(58 cases) and delayed application group(52 cases). Clinical data, arterial blood gas indexes before and 2 h after NPPV, duration time of NPPV, endotracheal intubation rate and fatality rate were analyzed. Results    Arterial partial pressure of oxygen and oxygen saturation of blood were significantly improved 2 h after NPPV in both groups(both P<0.05). In observation group, pH value(7.37±0.09 vs 7.28±0.08), arterial partial pressure of carbon dioxide(PaCO2)[(67±14)mmHg vs (82±19)mmHg], buffuer excess[10.5(6.9,14.2)mmol/L vs 10.2(5.4,12.9)mmol/L] and lactic acid concentration[0.8(0.6,1.3)mmol/L vs 1.1(0.7,1.6)mmol/L] were significantly improved after NPPV(all P<0.05). ΔpH andΔPaCO2 in observation group were significantly higher than those in control group(both P<0.001). Duration time of NPPV in observation group was significantly shorter than that in control group[5.0(2.0,9.3)d vs 6.5(4.0,9.0)d](P=0.048). There was no difference of intubation rate[3.8%(2/52) vs 0] and in-hospital fatality rate[11.5%(6/52) vs 3.4%(2/58)] between control group and observation group. Conclusion    Early application of NPPV in AECOPD patients with respiratory failure can effectively correct hypoxia and hypercarbia, ameliorate respiratory distress, improve clinical symptoms and shorten ventilation time.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭